Will Waxman Offer Seven Years Of Exclusivity For Follow-On Biologics?
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised bill is expected shortly as Reps. Eshoo and Barton draw battle line against the Commerce Committee chairman.